Question

In: Economics

Suppose a firm, Coronotech, owns the patent needed to produce a vaccine that prevents the contraction...

Suppose a firm, Coronotech, owns the patent needed to produce a vaccine that prevents the contraction of Covid-19, and thus is the only firm that can produce and sell this vaccine. Given that this is a huge scientific/medical breakthrough, the vaccine only needs to be received once and there are no close substitutes for this vaccine.

a.Use an Edgeworth box to represent this simple allocation economy. Make sure to locate the initial endowment and label it E. Measure goods for Bob from the lower left corner. Measure Krabby Patty burgers on the vertical sides and Jellyfish on the horizontal sides of the box. (Draw this carefully enough and large enough so that you can clearly add your answers for part (c) of this problem).

  1. Now let’s examine Coronotech’s situation more precisely. The total cost function of the firm is given by C(Q) = 32000 + 6Q, with Q measured in millions. Market inverse demand is given by P=6350-4Q. Find formulas for the MR curve, MC curve, and AC curve.
  2. e) Solve for the profit maximizing Q and P, and monopoly profit. Sketch the AC curve, MC curve, MR curve, and demand curve, labeling the profit maximizing quantity of vaccines and the monopoly price per vaccine. In no more than two sentences indicate how these cost curves differ from what you drew in part (a) and why they are reasonable for a vaccine product.
  3. f) Suppose that due to political pressure, the government decides to regulate the price, requiring Coronotech to charge the efficient price. What would be the price, quantity, and the profits for Coronotech, in this case? Is this a sustainable policy (would the firm stay in the business of making the vaccine)?
  4. g) If the government wants Coronotech to charge the lowest price that allows it to stay in business, what price should the government require? You do not need to calculate this price, just explain how the government would find this price. Would the quantity that corresponds to this price be higher, lower, or the same as the efficient quantity found in part (f)?

Solutions

Expert Solution

D) marginal revenue is the Increase in revenue by selling additional unit of good. It is derivative of total revenue with respect to Q.

TR=6350q-4Q2

MR=6350-8Q

MC=6

AC=32,000/Q +6

E) Monopoly equilibrium at ,MR=MC{ Profit Maximizing condition}

6350-8Q=6

Q=6344/8=793

P=6350-4*793=3178

F) Efficent price is, at which total economic surplus is Maximizing and it is Equal to perfect competition equilibrium price.

Perfect competition equilibrium at P=MC

6350-4Q=6

Q=6344/4=1596

P=6350-4*1596=6

Profit=(P-AC)*Q

AC=32,000/1596 +6=26.05

Profit=(6-26.05)*1596=-32000

Because firm is earning loss ,so they will leave the market and this will result in complete loss of economic surplus and benefit of vaccine.

G)A firm stay in business when they atleast earn normal Profit or zero economic profit.

To make them stay in business , goverment need to allow them to charge price ,where price and average cost is equal, which lead to firm making Normal Profit.

The quantity associated with this price will be lower than efficent Equilibrium quantity because this price will higher than efficent price and higher price lead to decrease in quantity demanded and thus quantity sold will be lower.


Related Solutions

Suppose that the patent grants a 5‐year exclusive right to produce the vaccine. Given that vaccines...
Suppose that the patent grants a 5‐year exclusive right to produce the vaccine. Given that vaccines are costly to develop, what will be the decision rule that will determine whether or not BSK will develop the vaccine? You can assume that the total cost and market demand curves are defined according to a 1‐year time horizon.
5. Suppose CP Manufacturing currently owns a machine that can produce a component needed for its...
5. Suppose CP Manufacturing currently owns a machine that can produce a component needed for its product. Suppose each unit of CP’s product requires one unit of the component. CP typically needs 1,000 units of this component in production each year. The costs of making the component are Direct material used in each unit $ 8 Variable manufacturing overhead for each unit 5 Direct labor utilized for each unit 10 Fixed overhead cost of maintaining the machine on a per...
Why are multiple vaccine doses still needed even if the adjuvant is present in the vaccine?
Why are multiple vaccine doses still needed even if the adjuvant is present in the vaccine?
A scientist has discovered the vaccine formula to the COVID-19 and received a patent for it...
A scientist has discovered the vaccine formula to the COVID-19 and received a patent for it (a legal monopoly). The scientist has signed a contract with a pharmaceutical company that will produce and sell the vaccine on the market. The monopoly pharmaceutical supplier faces an inverse demand curve P = 20 - (1/80)Q with marginal revenue MR = 20 – (1/40)Q, where Q is the output of vaccine in units and P is the market price per unit. The company...
Suppose that there is a fiscal contraction and a monetary contraction. This will cause: a. output...
Suppose that there is a fiscal contraction and a monetary contraction. This will cause: a. output and interest rates to both remain constant b. output to fall but interest rates may rise, fall, or remain the same c. output and interest rates to fall d. interest rates to fall but output may rise, fall, or remain the same
Firm A produces a product in high demand and it holds the sole legal authority to produce from patent protection.
Firm A produces a product in high demand and it holds the sole legal authority to produce from patent protection. The demand function is Qd=1,000,000-10P and the market supply curve is Qs=25P-125,000. The total cost function is C=$1,000,000,000+$5000Qs. Derived from C, we the marginal cost of the firm, MC=$5,000. a. What would be the equilibrium quantity and price if this were a perfectly competitive market? Demonstrate graphically the consumer surplus, producer surplus b. Now assume there is one firm (Firm...
Fields Laboratories holds a valuable patent (No. 758-6002-1A) on a precipitator that prevents certain types of...
Fields Laboratories holds a valuable patent (No. 758-6002-1A) on a precipitator that prevents certain types of air pollution. Fields does not manufacture or sell the products and processes it develops. Instead, it conducts research and develops products and processes which it patents, and then assigns the patents to manufacturers on a royalty basis. Occasionally it sells a patent. The history of Fields patent number 758-6002-1A is as follows. Date: Activity: Cost: 2001-2002 Research conducted to develop precipitator P384,000 Jan 2003...
Fields Laboratories holds a valuable patent (No. 758-6002-1A) on a precipitator that prevents certain types of...
Fields Laboratories holds a valuable patent (No. 758-6002-1A) on a precipitator that prevents certain types of air pollution. Fields does not manufacture or sell the products and processes it develops. Instead, it conducts research and develops products and processes that it patents, and then assigns the patents to manufacturers on a royalty basis. Occasionally it sells one of its patents. The history of Fields patent number 758-6002-1A is as follows. Date Activity Cost 2011 − 2012 Research conducted to develop...
Fields Laboratories holds a valuable patent (No. 758-6002-1A) on a precipitator that prevents certain types of...
Fields Laboratories holds a valuable patent (No. 758-6002-1A) on a precipitator that prevents certain types of air pollution. Fields does not manufacture or sell the products and processes it develops. Instead, it conducts research and develops products and processes which it patents, and then assigns the patents to manufacturers on a royalty basis. Occasionally it sells a patent. The history of Fields patent number 758-6002-1A is as follows. Date Activity Cost 2008–2009 Research conducted to develop precipitator $382,000 Jan. 2010...
Fields Laboratories holds a valuable patent (No. 758-6002-1A) on a precipitator that prevents certain types of...
Fields Laboratories holds a valuable patent (No. 758-6002-1A) on a precipitator that prevents certain types of air pollution. Fields does not manufacture or sell the products and processes it develops. Instead, it conducts research and develops products and processes which it patents, and then assigns the patents to manufacturers on a royalty basis. Occasionally it sells a patent. The history of Fields patent number 758-6002-1A is as follows. Date Activity Cost 2011–2012 Research conducted to develop precipitator $384,000 Jan. 2013...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT